Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples